Harmony Biosciences Holdings, Inc. (HRMY)
39.57
+0.30
(+0.76%)
USD |
NASDAQ |
Dec 11, 16:00
39.57
0.00 (0.00%)
After-Hours: 18:19
Harmony Biosciences Holdings EPS Diluted (Quarterly): 0.8663 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Halozyme Therapeutics, Inc. | 1.432 |
| Capricor Therapeutics, Inc. | -0.5375 |
| Nurix Therapeutics, Inc. | -1.027 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 50.86M |
| Revenue (Quarterly) | 239.46M |
| Total Expenses (Quarterly) | 188.59M |
| Enterprise Value | 1.816B |
| Gross Profit Margin (Quarterly) | 72.60% |
| Profit Margin (Quarterly) | 21.24% |
| Earnings Yield | 8.02% |
| Operating Earnings Yield | 9.75% |
| Normalized Earnings Yield | 8.025 |